BECN1 and Bloom syndrome: Similarly, in vivo results indicated that autophagic activity was markedly inhibited in the BLM group, as evidenced by the decreased expression of LC3B-II and Beclin-1 and increased level of p62 in the BLM group compared with the NS group; after TJ-5 administration, autophagic activity was significantly enhanced (Figure 5C).